344 related articles for article (PubMed ID: 20002080)
41. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
Zieba R
Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763
[TBL] [Abstract][Full Text] [Related]
42. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Lee M; Aronne LJ
Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
[TBL] [Abstract][Full Text] [Related]
43. Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States.
Suissa K; Schneeweiss S; Kim DW; Patorno E
Diabetes Obes Metab; 2021 Jul; 23(7):1542-1551. PubMed ID: 33651454
[TBL] [Abstract][Full Text] [Related]
44. Current pharmacotherapy for obesity.
Srivastava G; Apovian CM
Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993
[TBL] [Abstract][Full Text] [Related]
45. Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness.
Kouidrat Y; Amad A; De Hert M
Curr Pharm Des; 2015; 21(23):3317-24. PubMed ID: 26088113
[TBL] [Abstract][Full Text] [Related]
46. Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome.
Bourebaba Y; Mularczyk M; Marycz K; Bourebaba L
Biomed Pharmacother; 2021 Feb; 134():111113. PubMed ID: 33341043
[TBL] [Abstract][Full Text] [Related]
47. New medications for obesity management: changing the landscape of obesity treatment.
Boulghassoul-Pietrzykowska N; Franceschelli J; Still C
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):407-11. PubMed ID: 23974768
[TBL] [Abstract][Full Text] [Related]
48. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
Scheen AJ; Van Gaal LF
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):911-22. PubMed ID: 24731666
[TBL] [Abstract][Full Text] [Related]
49. [Pharmacotherapy for obesity].
Bruun JM
Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050
[TBL] [Abstract][Full Text] [Related]
50. Diabesity: therapeutic options.
Colagiuri S
Diabetes Obes Metab; 2010 Jun; 12(6):463-73. PubMed ID: 20518802
[TBL] [Abstract][Full Text] [Related]
51. Obesity and type 2 diabetes: Also linked in therapeutic options.
Rubio-Almanza M; Cámara-Gómez R; Merino-Torres JF
Endocrinol Diabetes Nutr (Engl Ed); 2019 Mar; 66(3):140-149. PubMed ID: 30337188
[TBL] [Abstract][Full Text] [Related]
52. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
Leung WY; Thomas GN; Chan JC; Tomlinson B
Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
[TBL] [Abstract][Full Text] [Related]
53. [Drug treatment of obesity--current situation and perspectives].
Hainer V
Cas Lek Cesk; 2010; 149(11):513-9. PubMed ID: 21391349
[TBL] [Abstract][Full Text] [Related]
54. [Recent progress and novel perspectives on obesity pharmacotherapy].
Faria AM; Mancini MC; Melo ME; Cercato C; Halpern A
Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):516-29. PubMed ID: 20857056
[TBL] [Abstract][Full Text] [Related]
55. Drug treatments for obesity: orlistat, sibutramine, and rimonabant.
Padwal RS; Majumdar SR
Lancet; 2007 Jan; 369(9555):71-7. PubMed ID: 17208644
[TBL] [Abstract][Full Text] [Related]
56. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
57. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
[TBL] [Abstract][Full Text] [Related]
58. Paediatric obesity: can medications help.
Lenders CM
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):331-9. PubMed ID: 26218173
[TBL] [Abstract][Full Text] [Related]
59. Novel therapies for cardiometabolic risk reduction and implications for clinical practice.
Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S37-42. PubMed ID: 17934393
[TBL] [Abstract][Full Text] [Related]
60. Pharmacotherapy for obese adolescents.
Greydanus DE; Bricker LA; Feucht C
Pediatr Clin North Am; 2011 Feb; 58(1):139-53, xi. PubMed ID: 21281853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
